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Methionine sulfoxide reductases (Msrs) are oxidoreductases
that catalyze thiol-dependent reduction of oxidized methioni-
nes.MsrA andMsrB are the best knownMsrs that repair methi-
onine-S-sulfoxide (Met-S-SO) and methionine-R-sulfoxide
(Met-R-SO) residues in proteins, respectively. In addition, an
Escherichia coli enzyme specific for free Met-R-SO, designated
fRMsr, was recently discovered. In this work, we carried out
comparative genomic and experimental analyses to examine
occurrence, evolution, and function of fRMsr. This protein is
present in single copies and two mutually exclusive subtypes in
about half of prokaryotes and unicellular eukaryotes but ismiss-
ing in higher plants and animals. A Saccharomyces cerevisiae
fRMsr homolog was found to reduce freeMet-R-SO but not free
Met-S-SO or dabsyl-Met-R-SO. fRMsr was responsible for
growth of yeast cells onMet-R-SO, and the double fRMsr/MsrA
mutant could not grow on a mixture of methionine sulfoxides.
However, in the presence of methionine, even the triple fRMsr/
MsrA/MsrB mutant was viable. In addition, fRMsr deletion
strain showed an increased sensitivity to oxidative stress and a
decreased life span, whereas overexpression of fRMsr conferred
higher resistance to oxidants. Molecular modeling and cysteine
residue targeting by thioredoxin pointed to Cys101 as catalytic
and Cys125 as resolving residues in yeast fRMsr. These residues
as well as a third Cys, resolving Cys91, clustered in the structure,
and each was required for the catalytic activity of the enzyme.
The data show that fRMsr is the main enzyme responsible for
the reduction of free Met-R-SO in S. cerevisiae.
Among the 20 common amino acids in proteins,Met andCys
are the residues most susceptible to oxidation by reactive oxy-
gen species (ROS).3 Upon oxidation, Met forms a diastereo-
meric mixture of methionine-S-sulfoxide (Met-S-SO) and
methionine-R-sulfoxide (Met-R-SO). Met-S-SO and Met-
R-SO can be reduced back to Met by MsrA (Met-S-SO reduc-
tase) and MsrB (Met-R-SO reductase), respectively (1). These
enzymes have been reported to play important roles in the pro-
tection of cells and proteins against oxidative stress (2–8).
Reversible Met oxidation has also been proposed to scavenge
ROS, thereby protecting cells from oxidative damage (9–11).
IncreasedexpressionofMsrAandMsrBcanextend the life spanof
yeast cells and fruit flies, whereas deletion of theMsrA gene leads
to the reduction in life span inmice and yeast (12–14).
Previously, three MsrB isozymes and a single MsrA were
found in mammals. MsrB1 (also known as SelR or SelX) is a
selenoprotein, which contains selenocysteine (Sec) in the active
site and is localized to cytosol and nucleus. MsrB2 and MsrB3
are Cys-containing homologs ofMsrB1.MsrB2 resides inmito-
chondria, whereas human MsrB3 has two alternative splice
forms, whereinMsrB3A localizes to the endoplasmic reticulum
and MsrB3B is targeted to mitochondria (15).
The catalytic mechanism of MsrA involves a sulfenic acid
intermediate at the catalytic Cys followed by the formation of a
disulfide bond between the catalytic and resolving Cys. A third
Cys may then form a disulfide with the resolving Cys (16, 17).
The resulting disulfide is reduced by thioredoxin or other oxi-
doreductases, generating the initial, reduced form of the pro-
tein. X-ray structures of MsrAs from several organisms have
been solved (17, 18).
Cys-containing MsrBs (e.g. mammalian MsrB2 and MsrB3)
follow the same mechanism, although the two Msr types have
no homology and are characterized by different structural folds
(19–21). Sec-containing mammalian MsrB1 has also been
characterized and compared with Cys-containing MsrBs (20).
Interestingly, Cys-containingMsrBs share some active site fea-
tures (e.g. conserved residues His77, Val81, and Asn97, number-
ing based on mouse MsrB1 sequence), which are absent in sel-
enoprotein MsrB1s. When these three residues were
introduced into the Sec-containing MsrB1, the enzyme was
inactive. However, when the three residues were introduced
into the Cys mutant form of MsrB1, the activity was partially
recovered (20). This evidence supports the idea that catalytic
Cys and Sec require different active site features.
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In addition to MsrA and MsrB functions, previous studies
suggested the presence of additional Msr activities in Esche-
richia coli and yeast cells, which were especially evident in cells
deficient in both enzymes (14, 21–23). Recently, Lowther and
colleagues (24) discovered a new enzyme, designated fRMsr
(free Met-R-SO reductase), which catalyzes the reduction of
free Met-R-SO in E. coli. They showed that this activity is asso-
ciated with a GAF-like-domain-containing protein. Homologs
of this enzyme were found in other bacteria as well as in
eukaryotes, suggesting that these proteins also could function
as fRMsrs. However, none of these other proteins have been
functionally characterized.
In this work, we cloned a yeast homolog of bacterial fRMsr
and functionally characterized it with regard to the in vivo func-
tion and catalytic mechanism. In addition, we carried out com-
parative genomic analyses to examine evolution of this protein
family. The data show that fRMsr is the main enzyme respon-
sible for the reduction of free Met-R-SO in both prokaryotes
and unicellular eukaryotes.
EXPERIMENTAL PROCEDURES
Materials—E. coli NovaBlue cells (Novagen) were used for
DNA manipulation and BL21 (DE3) cells (Invitrogen) for pro-
tein expression. Restriction enzymes were from Fermentas,
PCR reagents were from Invitrogen, and Talon polyhistidine
affinity resin was from Clontech.
Comparative Genomic Analyses of fRMsrs in Prokaryotes and
Eukaryotes—Sequenced genomes of archaea, bacteria and
eukaryotes were retrieved from the NCBI Web site. A total of
540 bacterial, 48 archaeal, and 160 eukaryotic organisms were
analyzed (as of March 2008). We used E. coli (NP_416346) and
Saccharomyces cerevisiae fRMsr proteins (NP_012854) as our
seed sequences to search for homologs in other organisms.
TBLASTN (25) was used with default parameters. Orthologous
proteins were defined as bidirectional best hits (26).
Multiple Sequence Alignment and Phylogenetic Analysis—A
phylogenetic tree based on concatenation of 31 orthologs
occurring in 191 species (27) was used to analyze the distribu-
tion of organisms that do or do not contain fRMsrs. Multiple
sequence alignments were performed using ClustalW (28) with
default parameters and ambiguous alignments in highly vari-
able regions were excluded. Phylogenetic trees were recon-
structed with PHYLIP programs (29). Neighbor-joining trees
were obtained with NEIGHBOR, and the most parsimonious
trees were determined with PROTPARS. The robustness of
these trees was evaluated by maximum likelihood analysis with
PHYML (30) and Bayesian estimation of phylogeny with
MrBayes (31).
Computational Analysis of the Active Site of Yeast fRMsr—In
silico analysis of the active site was carried out using the struc-
ture of oxidized yeast fRMsr with Protein Data Bank code
1F5M. The structure was adjusted with the program VegaZZ
2.2.0 (available on theWorldWideWeb) to reduce the disulfide
bond and protonate residues andminimized (60 steps of 0.05Å,
steepest descent global minimization) with UCSF Chimera
(available on the World Wide Web). The active site was ana-
lyzed with Q-site finder (available on the World Wide Web),
which assesses residue accessibility to a small molecular probe
and then ranks up to 10 potential active sites (32). The top-
ranked predicted active sites were considered as themost prob-
able sites of catalysis. The theoretical titration data for each
putative catalytic Cys were obtained using the H server
(available on theWorldWideWeb) (35), which calculates the-
oretical pKa values and estimates variation of the charge state
on the titrable atom of each titrable residue at different pH
values. These values were then superimposed with the calcu-
lated curves for a typical HH behavior at the corresponding
theoretical pKa. The assumptions were that deviating titrable
residues more frequently occur in enzyme active sites (33, 34,
36) and that the theoretical titration curves may indicate the
tendency of the residue to be catalytic. Finally, visual inspec-
tions of the titration curves were carried out for curves with the
largest deviation from the standard HH behavior as candidate
residues of the active site (33, 36).
Computational Docking of Met-R-SO into fRMsr Active Site
and Molecular Dynamics—The structure of yeast fRMsr
(1F5M) was prepared for docking using VegaZZ 2.2.0, Argus-
Lab 4.0 (available on the World Wide Web) and the Autodock
(available on theWorldWideWeb) suite of programs. VegaZZ
was also employed to prepare the Met-R-SO substrate (down-
loaded from the ZINC data base). The SP4 force field and the
AMMP-mommethodwere employed to assign charges toMet-
R-SO and to minimize the structure. The substrate was then
exported to ArgusLab. The yeast fRMsr structure was virtually
reduced with VegaZZ building tools. The structure for the
reduced protein was treated with Tinker (available on the
WorldWideWeb) for extensiveminimization dynamics. Using
the AMBER99 force field and gradient convergence per atom
criterion of 0.01 kcal/mol/Å, the reduced structure employed in
the docking calculation was obtained. Molecular dynamics
experiments were done with Tinker, using the dynamics
option. We conducted first nonboundary dynamics starting
from the reduced, but not minimized, structure. We sampled
time steps in the range 0.01–1.0 fs and overall dynamics time up
to 200 ps and performed calculations assuming 300 K and 1
atmosphere. After evaluation of the time range (0–1 ps), in
which the clear movement of the active site Cys was detectable,
we carried out final calculations with the following parameters:
time step  0.1 fs, number of steps  1,000,000, and dumps
time  0.05 ps. Analysis of trajectories was done with Tinker
and VegaZZ; the root mean square fluctuation (standard defi-
nition) of carbon alpha was calculated starting from the struc-
tures of our ensemblewith in-house programs. For docking, the
substrate was analyzed in the intercalation site using a docking
box of 20  20  20 Å centered at the approximate center of
mass of the two candidate catalytic Cys residues (Cys101 and
Cys125). We employed the GAdock docking engine, a genetic
algorithm search technique implemented in ArgusLab. To set
up the docking parameters, calculations were made with the
following values: population size 250, maximum generations
100,000, mutation rate 0.02, grid resolution 0.1 Å, and flexible
ligand mode (other parameters were kept with default values).
Docking calculations with AutoDock 4 were run in Linux envi-
ronmentmaking use of the ADT graphical user interface (avail-
able on the World Wide Web). We imported the same Met-
R-SO and yeast fRMsr structures employed for ArgusLab
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dockings. Although with ArgusLab, the protein structure was
forced to be rigid during the docking, with AutoDock it was
possible to define a subset of flexible amino acids that were free
to move during the docking. We defined as flexible the follow-
ing residues: Tyr70, Leu80, Val89, Ala90, Cys91, Ile94, Gly99,
Val100, Cys101, Gly102, Thr103, Ala104, Ala105, Ile123, Ala124,
Cys125, and Asp126. These residues can be considered as an
extended reaction center around the three Cys residues (posi-
tions 91, 101, and 125). Again, the docking box 20 20 20 Å
was centered around the approximate center ofmass of the two
candidate catalytic Cys residues (Cys101 and Cys125). We
employed the genetic algorithm search with the following
parameters: population size 250,maximumgenerations 50,000,
mutation rate 0.02, maximum number of energy evaluation
10,000,000, grid resolution 0.2 Å, and flexible ligand mode.
Images were prepared with UCSF Chimera, VegaZZ, and
PyMol (available on the World Wide Web) packages.
Preparation and Verification of Msr Mutant Strains—The
yeast strains used in this study were derivatives of wild type
BY4741 cells. Mutants missing two or three Msr genes were
generated by a one-step gene disruptionmethod usingmarkers
described in Table S1 (40). The HIS3 marker was amplified
from p423 vector with the following primers: 5-CGGTTTCT-
TCATGTTTATATGATGACGATTTTCCCAAATGTAAG-
CAAACAAAGGCGACTGCCAGGTATCGTTTGAACACG-
3 and 5-TGCCCGTCCGACAATATATTTGACAAGAGA-
GCTACATGGGAATATTGGTTATGTCGTATGCTGCAG-
CTTTAAATAATCGG-3. PCR products were purified from
agarose gel and used for yeast transformation. Mutant clones
were selected in minimal histidine-free medium. Deletions of
each open reading frame were confirmed by PCR. Yeast strains
used in this study are listed in Table S1.
Cloning, Expression, and Purification of Yeast fRMsr—The
gene coding for fRMsr was amplified from yeast genomic DNA
with the following primers (restriction enzyme sites NdeI and
NotI are underlined): fRMsr-F 5-AAACATATGATGGGCT-
CATCAACCGGGTTTC-3 and fRMsr-R 5-AAGCGGCCG-
CGACACATGATTTATTAATTAATTTAGCAAG-3. The
PCR product was digested with NdeI and NotI and cloned into
pET21b vector (Novagen) and then transformed into E. coli
NovaBlue cells. The constructs were verified by restriction
enzyme digestion and direct sequencing. The plasmid harbor-
ing the correct insert was transformed into E. coli BL21 (DE3)
cells for protein expression. These cells were grown in LB
medium containing 100 g/ml ampicillin until A600 reached
0.8, and isopropyl 1-thio--D-galactopyranoside was added to a
final concentration of 0.25 mM. Induction of protein synthesis
proceeded at 30 °C for 4 h, and cells were then harvested by
centrifugation at 4,000 rpm. Cell pellets were washed with
phosphate-buffered saline and recentrifuged. Harvested cells
were stored at70 °C until use.
To purify recombinant protein, cell pellets were mixed with
resuspension buffer (50mMTris-HCl, pH7.5, 15mM imidazole,
300mMNaCl), and phenylmethylsulfonyl fluoridewas added to
a final concentration of 0.5 mM. After sonication, the superna-
tantwas collected by centrifugation at 8,000 rpm for 30min and
loaded onto a cobalt Talon resin (Clontech) pre-equilibrated
with resuspension buffer. Following washing with the same
buffer, the protein was eluted with elution buffer (50 mM Tris-
HCl, pH 7.5, 300 mM imidazole, 300 mM NaCl). The eluted
fractions were analyzed by SDS-PAGE, and the fractions con-
taining fRMsr were pooled and dialyzed overnight against
phosphate-buffered saline in a dialysis cassette (Pierce).
Site-directed Mutagenesis of fRMsr—Substitutions of Cys
with Ser at positions 91, 101, and 125were carried out using the
QuikChange protocol (Stratagene) with the following primers:
C91Sf, 5-GGAAAGGTCGCTAGCCAAATGATTC-3; C91Sr,
5-GAATCATTTGGCTAGCGACCTTTCC-3; C101Sf, 5-
GGTAAAGGTGTTAGCGGAACTGCAGC-3; C101Sr, 5-
GCTGCAGTTCCGCTAACACCTTTACC-3;C125Sf, 5-GTC-
ATATTGCGAGCGACGGTGAAAC-3; C125Sr, 5-GTTTC-
ACCGTCGCTCGCAATATGAC-3. After PCRs, wild type
template was digested with DpnI, and the PCR products were
transformed into E. coli NovaBlue cells. Mutations were con-
firmed by DNA sequencing. Plasmids carrying correct muta-
tions were transformed into E. coli BL21(DE3), and protein
expression was carried out as described above.
Determination of fRMsr Activity—The reaction mixture (20
l in phosphate-buffered saline, pH 7.4) included 50 mM dithi-
othreitol (DTT), 1mM substrate (Met-R-SO orMet-S-SO), and
the reaction was initiated by the addition of purified enzyme.
The reaction proceeded at 37 °C for 30 min and then was
stopped by adding 2 l of trichloroacetic acid. After further
incubation at 4 °C for 10 min and centrifugation at 13,000 rpm
for 15 min, the supernatant (5 l) was mixed with the OPA
derivatization reagent to a 100-l final volume as described (8).
Following a 2-min reaction at room temperature, 50 l of the
mixture were injected onto a Zorbax Eclipse XDB-C8 column
(4.6 150mm) initially equilibrated at room temperature with
20 mM sodium acetate, pH 5.8 (solvent A) and methanol (sol-
vent B) at a ratio of 88:12 (v/v). Met was separated at room
temperature at a flow rate of 1.5 ml/min using a linear gradient
of 12–40% methanol from 0 to 5 min, 40–47% methanol from
5 to 40 min, and 47–100% methanol from 40 to 45 min. Detec-
tion was by fluorescence of Met derivatives using aWaters 474
scanning fluorescence detector with excitation at 330 nm and
emission at 445 nm.
The reduction of free Met-R-SO was also determined by a
coupled assay. Briefly, a 100-l reactionmixture contained 5g
of purified fRMsr, 5 g of E. coli thioredoxin (Trx), 0.5 l of
E. coli thioredoxin reductase (Sigma), 0.4mMNADPH, and free
Met-R-SO. The reaction was allowed to take place at 37 °C for
15 min, 200 l of phosphate-buffered saline was added to the
reaction mixture, and NADPH oxidation was analyzed imme-
diately at A340. The activity was calculated using an NADPH
extinction coefficient (6220 M1 cm1) (41).
Viability Assays and Oxidative Stress Resistance—Yeast
strainswere grown in liquidmediumovernight and then seeded
into fresh liquid medium at an A600 of 0.1. The cultures were
allowed to reach an A600 of 0.4–0.5, diluted to an A600 of 0.1–
0.2, and used for viability assays. Briefly, 50 l of yeast culture
was inoculated into 1 ml of liquid medium, and of that, 50 l
was diluted into 450l ofmediumand used to count colonies at
time 0. H2O2 was then added, at the indicated concentrations,
to 1-ml cultures, and the cells were further incubated at 30 °C.
At 30, 60, and 120min after treatment, 50l of each culturewas
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diluted into 450 l of liquid medium. To count viable colonies,
the diluted cultures were mixed with 3 ml of liquid medium
supplemented with 0.4% agarose held in a water bath at 42 °C,
and the resulting mixtures were poured onto agar plates con-
taining the same medium components as the liquid medium.
Viability of wild type and deletionmutant strainswas assayed in
YPD or YNB medium, and those of wild type strains overex-
pressing vector or yeast fRMsr were assayed in YNB medium
without histidine.
For plate assays, overnight cultures of wild type and deletion
mutant strains were adjusted to an A600 of 2.5, 0.25, 0.025, and
0.0025 via serial dilution. Eachdiluted sample (5l) was spotted
onto YNB agar medium in the presence or absence of indicated
concentrations of H2O2, and cell growth was quantified after
incubation for 3 days at 30 °C.
Analysis of Microarray Data—Data on expression levels
of fRMsr (GDS777/10627_at/YKL069W), MsrA (GDS777/
5697_at/MXR1), and MsrB (GDS777/6899_at/YCL033C) at
different nutrient-limiting conditions (i.e. carbon, nitrogen,
phosphorus, and sulfur) and at different oxygen availability (i.e.
aerobic and anaerobic) were collected from GEO profiles (42).
Data from three single channels were averaged, and S.D. values
were calculated.
Preparation of Human Thioredoxin 1 (hTrx1) C35SMutant-
immobilized Resins and Cys Targeting—C35S hTrx1-immobi-
lized resins were prepared to trap resolving cysteines of fRMsr.
Briefly, mutant C35S hTrx1 in 0.1 M sodium carbonate buffer
(pH 8.5) containing 0.5 M NaCl was incubated with cyanogen
bromide-activated Sepharose 4B (Sigma) that had been swelled
according to the manufacturer’s instructions. The coupling
reaction was stopped by centrifugation, and unreacted side
chains on the resin were blocked with 0.2 M glycine (pH 8.0) for
2 h at room temperature. After extensivewashingwith the basic
coupling buffer described above and acetate buffer (0.1 M, pH 4)
several times, immobilized C35S hTrx1 was quantified based
on the difference between the amounts of protein initially used
and remaining in solution after the coupling reaction. To search
for residues targeted by C35S hTrx1, various fRMsr forms (wild
type, C91S, C101S, C125S, or C101S/C125S; 50 g of each)
were incubatedwith 0.5ml of C35S hTrx1-immobilized resin at
room temperature for 2 h under gentle stirring. Immobilized
C35S hTrx1 was initially reduced with 1 mM DTT for 30 min
and washed with 50 mM sodium phosphate buffer (pH 7.5, 50
mMNaCl). After incubating the C35S hTrx1-immobilized resin
with each fRMsr form at room temperature for 2 h, the resins
were suspended in 50 mM sodium phosphate buffer (pH 7.5, 50
mMNaCl, 10mMDTT) and incubated at room temperature for
30min. During the whole process, initial samples prior to incu-
bation with the C35S hTrx1-immobilized resin, flow-through
samples after incubation with the resin, and elution samples
after 10 mM DTT treatment were collected, and 10 l of each
fraction were loaded on SDS-polyacrylamide gels and visual-
ized by Western blot with anti-fRMsr antibodies.
RESULTS
Comparative Genomics of fRMsrs—Analysis of completely
sequenced genomes revealed a restricted (comparedwithMsrA
andMsrB) use of fRMsr (a list of analyzed organisms is shown in
Table S2). 41.5% of all examined bacteria, 6% of archaea, and
44.4% of eukaryotes were found to possess this protein, and
each of these organisms contained a single copy of fRMsr. The
distribution of fRMsrs was further analyzed in detail in bacteria
(Fig. S1), archaea (Fig. S2), and eukaryotes (Fig. S3) based on a
highly resolved tree of life (27) (see supplemental material).
Interestingly, the occurrence of this protein was limited to uni-
cellular organisms, whereas higher plants and animals lacked
this protein.
Two variants (or subtypes) of fRMsr proteins were detected.
Both contained two fully conserved Cys residues (i.e. Cys101 and
Cys125 in S. cerevisiae fRMsr) that were absent in other GAF
domain-containing proteins. Thus, these two residues represent a
signature for the identification of fRMsr sequences. Type I fRM-
srs possessed an additional conserved Cys (e.g. Cys91 in S. cer-
evisiae fRMsr), which was invariantly absent in type II fRMsrs.
Occurrence of the two fRMsr types is shown in Figs. S1–S3, and
multiple alignment of fRMsr sequences is shown in Fig. 1. No
organism possessing both fRMsr types was detected. Type II
fRMsrs had lower occurrence and were found in 26 bacteria, 3
archaea, and 2 eukaryotes characterized by complete genome
sequences. Phylogenetic analysis was used to further examine
the evolutionary relationships of the two types of fRMsrs in
different organisms (Fig. S4).
We also examined domain fusions involving fRMsr in
eukaryotes and prokaryotes (Fig. 2). One example involved type
I fRMsr that was fused with a homolog of TIP41 (pfam04176;
TIP41-like family) (24) in Kinetoplastida (including Leishma-
nia and Trypanosoma; Fig. 2A). TIP41 was reported to be
involved in the regulation of yeast type 2A phosphatases (43).
However, the functional relationship between TIP41 and
fRMsr is not clear. Similarly, in bacteria, all type II fRMsrs in
sequenced Thermotogaes contained an unknown N-terminal
domain (designated Unknown_1, Fig. 2B). In Fervidobacterium
nodosum, which belongs to Thermotogae, an additional
GGDEF domain (pfam00990) was found to be fused at the C
terminus of fRMsr (Fig. 2C).
Overall, functional genomics analysis of fRMsr homologs
revealed the presence of these proteins in all three domains of
life. fRMsr showed a lower occurrence thanMsrA orMsrB and
also was present in single copies in organisms containing this
protein. Our data suggested that all fRMsr sequences may have
a similar function; by analogy to the E. coli fRMsr, which natu-
rally reduces free Met-R-SO, other organisms also could use
fRMsr for this function.
fRMsr Is Important for Met-R-SO Consumption and Growth
of Yeast Cells on Met-R-SO—For functional characterization,
we chose a S. cerevisiae fRMsr homolog (YKL069W), which
is annotated as a putative protein of unknown function. We
prepared mutant cells deficient in fRMsr and its double
mutants with MsrA or MsrB. We first examined the growth
of these and wild type cells on YNB agarmedium inwhichMet
was substituted with Met-R-SO or Met-S-SO. Fig. 3A shows
that the deficiency in fRMsr, MsrA, or MsrB only slightly
decreased the growth of yeast cells on Met-R-SO. The growth
was reduced more significantly when both MsrA and MsrB
genes were deleted (44). Interestingly, deletion of fRMsr and
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MsrA completely blocked the
growth of yeast cells, suggesting that
these two proteins were responsible
for the reduction of Met sulfoxides
in S. cerevisiae. In this regard, the
growth of the fRMsr mutant strain
on Met-R-SO may be explained by
the presence of small amounts of
Met-S-SO in the Met-R-SO prepa-
ration or by the lower requirement
for Met in this assay.
In the medium where Met was
replaced with Met-S-SO (Fig. 3B),
deletion of fRMsr or MsrB had no
effect on the growth of yeast cells;
however, deletion of MsrA reduced
the growth significantly. The com-
bined MsrA and fRMsr deficiency
FIGURE 1.Multiple sequence alignment of fRMsr proteins. The alignment shows regions containing the three conserved Cys in both types of fRMsr. Conserved
residues are highlighted. The predicted functional Cys residues are shownwith asterisks. Distant fRMsr homologs, GAF domain proteins, are shown for comparison.
FIGURE 2. Domain fusions involving fRMsr proteins. A, fRMsr fused with TIP41-like domain (pfam04176) in
Kinetoplastida.B, fRMsr fusedwith anunknowndomainUnknown_1 in Thermotogae.C, fRMsr fusedwithboth
Unknown_1 and GGDEF domain (pfam00990) in F. nodosum.
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further reduced the growth of yeast cells. Again, a small
contribution of fRMsr to the growth of MsrA-deficient cells on
Met-S-SO may be explained by trace amounts of Met-R-SO
present in the Met-S-SO preparation. None of the mutant
strains showed significant growth defects in Met medium (Fig.
3C). The results of the assay in liquid medium containing Met-
R-SO instead ofMet are shown in Fig. 3D. The complete growth
inhibition of the fRMsr mutant in Met-R-SO medium was
observed in this liquid culture assay. To further examine
Met-SO reduction in S. cerevisiae, we prepared and character-
ized amutant strain lacking all three enzymes (i.e.MsrA,MsrB,
and fRMsr). The triple mutant overexpressing fRMsr was
shown to restore the growth. These data clearly demonstrate
the role of fRMsr in the reduction of free Met-R-SO. Overall,
the data show that fRMsr is the main enzyme responsible for
Met-R-SO reduction in yeast and probably other organisms,
and that MsrA is the main enzyme reducing free Met-S-SO.
Yeast fRMsr Serves as anAntioxidant Protein—Wild type and
fRMsr mutant strains as well as cells transformed with control
vector or the vector expressing fRMsrwere tested for sensitivity
to oxidative stress. Strains deleted for the MsrB gene or over-
expressing this protein were included for comparison. As
shown in Fig. 4A, in the presence of 1 mMH2O2, deletion of the
fRMsr gene resulted in reduced viability at 30 min. Fig. 4B
shows that, in the presence of 1 mM H2O2, the yeast cells over-
expressing fRMsr showed an increased resistance to peroxide
treatment (compared with control cells). The antioxidant role
of fRMsr was further confirmed in plate assays (Fig. 4C). The
fRMsr mutant was more sensitive to H2O2-mediated cell death
compared with wild type cells. However, the deletion of fRMsr
affected sensitivity to oxidative stress less than that ofMsrA or
MsrB. Thus, fRMsr as well as MsrA and MsrB serve as antioxi-
dants in yeast cells.
A recent study examined global gene expression in yeast cells
under the limitation of nutrients, such as carbon, nitrogen,
phosphorus, and sulfur as well as examined the effect of oxygen
availability (42). Expression data for fRMsr, MsrA, and MsrB
were retrieved from GEO profiles and are shown in Fig. S5.
Under aerobic conditions, fRMsr gene expression was elevated
when sulfur was limiting in the growthmedium.MsrAwas also
elevated, but MsrB was not. However, under anaerobic condi-
tions, neither fRMsr nor MsrA gene expression was affected
when sulfur was limiting in the medium. These data suggest
that, in the presence of oxygen (when ROS levels are higher),
MsrA and fRMsr (but not MsrB) probably contribute to sulfur
acquisition by reducingMet-S-SO andMet-R-SO, respectively.
Roles of Yeast fRMsr in Aging—Wild type and mutant strains
deficient in individual Msrs and their combinations were ana-
lyzed for life span in a replicative assay of yeast aging. Deletion
of MsrB did not influence life span, whereas fRMsr and MsrA
mutant strains showed a reduced life span (18 and 30%, respec-
tively) (Fig. 5A). To further elucidate the role of fRMsr in aging,
the life spans of fRMsrMsrA, fRMsrMsrB, and
fRMsrMsrAMsrB cells were determined. These strains
showed 20% reduction in life span compared with wild type
cells, which was not significantly different from the life span of
cells lacking only fRMsr. fRMsr overexpression did not extend
yeast life span in cells grown inminimal YNBmedium (Fig. 5B).
Characterization of Catalytic Properties of fRMsr—To
explore enzymatic properties of yeast fRMsr, we expressed
this protein in E. coli as a His-tagged protein and examined
its catalytic properties. The recombinant protein had robust
Met-R-SO reductase activity but was inactive with Met-
S-SO as well as dabsylated Met-R-SO. Kinetic parameters
derived by fitting the experimental data onto the Michaelis-
Menten equation are shown in Fig. 6. The enzyme had a Vmax
value of 443 nmol/min/mg protein, and its Km value for free
Met-R-SO was 230 M.
Identification of Catalytic Cys in fRMsr—We searched for
catalytic Cys in S. cerevisiae fRMsr by analyzing properties of
the active site in this protein. The Q-site finder prediction
placed three Cys residues (Cys91, Cys101, and Cys125) in the
most probable enzymatic cleft for fRMsr. The same three Cys
residues were also identified in E. coli fRMsr (24). However,
althoughCys101 andCys125 provided their sulfur atoms for pos-
sible substrate binding, only the backbone atoms of Cys91 were
involved. The best scoring predicted active site was composed
FIGURE3.RolesofMsrs inutilizationofMet-SOby S. cerevisiae cells.Yeast
strains were analyzed for growth on Met-free YNB medium supplemented
with 20 mg/liter Met-R-SO (A), Met-S-SO (B), or Met (C). Cells were initially
grown on YNB liquid medium until A600 reached 0.6, harvested, washed,
diluted to A600 of 0.1 in water, and serially spotted on agar YNB plates con-
taining respectiveMet orMet-SO sources. The plateswere incubated at 30 °C,
andpictureswere takenafter 48h.Designationsof yeast strains are as follows:
A, cells with MsrA gene deleted: B, cells missing the MsrB gene: F, cells
with deletion of the fRMsr gene. Cells missing multiple Msrs were also ana-
lyzed as shown as well as mutant cells containing a vector (v) or expressing
fRMsr (pF).D, growthofwild type andmutant strains of S. cerevisiae in liquid
medium (Met-free YNB supplemented with 20 mg/liter Met-R-SO). The
growth of yeast cells was monitored by measuring A600. Designations of WT
and mutant cells are as in A–C.
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of Trp66, Tyr70, Ala90, Ile94, Glu99, Val100, Cys101, Val116, His112,
Ile122, Ala124, Cys125, Asp126, Thr129, Glu132, Asp149, andAsp151
(Fig. S6).
We further analyzed the theoretical titration behavior for
Cys91, Cys101, and Cys125 using the H server to fit into the
standard HH curve (Fig. S7). The deviating fitting was more
pronounced for Cys125 and Cys101, but Cys91 showed a nonde-
viating curve similar tomost residues in proteins (35), including
Cys177 in fRMsr. On the assumption that highly deviating
titrable residues are often located in enzyme active sites (33, 34,
36), these results suggested Cys125 or Cys101, but not Cys91, as
the residues directly involved in reducing free Met-R-SO.
Cys125 was in close proximity to two other titrable residues
showing HH deviating behavior, Tyr70 and Asp151, whereas
Cys101 clustered with highly deviating Glu132 and Asp149. Alto-
gether, computational analyses suggested that Cys125 and
Cys101 were candidate catalytic residues, whereas Cys91 was
not.
To further analyze Cys residues participating in catalysis
and to characterize the reaction mechanism of fRMsr, we
carried out computational docking of Met-R-SO into the
active site of the enzyme as described under “Experimental
Procedures.” Employing different methodologies, we consis-
tently observed the same Met-R-SO-binding site in yeast
fRMsr (shown as a cluster of scoring models in Fig. S6).
Among these models, the best scoring candidate (interaction
energy of 8.1 kcal/mol) is shown in Fig. 7. This binding
structure was detected by both AutoDock and ArguLab, with
the substrate close to both Cys101 and Cys125 and pointing
the sulfoxide moiety toward the
sulfur atom of Cys101 (at a distance
of 2.4 Å). Cys125 appeared to ori-
ent the substrate to react with
Cys101. Given that this model was
reproduced with different dock-
ing methods and received good
scores, our data suggested that
Cys101 is the catalytic residue, and
Cys125 is the initial resolving Cys. In
addition, we observed that Cys125
was remarkably more mobile than
either Cys91 or Cys101 (the latter is
least mobile of the three) (Fig. 8).
Following reduction of the disulfide
bond, Cys125 moves away from
Cys91 (from 2.1 to 6.9 Å), coming
closer to Cys101 (from 7.1 to 4.6 Å)
and Asp151.
Our reduced structure model (i.e.
the most stable reduced form of the
protein) presents a Cys125–Asp151
distance of 3.6 Å, taken as the short-
est atomic distance between the two
residues (Fig. 8), which is very simi-
lar to the previously observed dis-
tance (3.5 Å) of the reduced form of
yeast fRMsr (45). In this work, it was
found that Cys125 occurs in two dif-
ferent conformations when in oxidized and reduced forms, the
latter positioned near Asp151 and away from Cys91. Thus, our
data are consistent with the previous structural analysis (45)
and further suggested that Cys125 is the most mobile Cys in the
active site.
We carried out molecular dynamics calculations to further
address Cys125 mobility in a short time scale (0–200 ps). The
movement of Cys125 was very quick (within 1 ps; Fig. S8). At the
same time, other Cys were stationary preserving their initial
positions. Following the initial movement, Cys125 mobility was
not significantly different compared with the other active site
residues (i.e. its fluctuations were comparable with those of
Cys91 and Cys101). Thus, Cys125 is initially the most mobile
active site Cys, in agreementwith the expected properties of the
resolving Cys.
Catalytic Activity of fRMsr Mutants and Cys Targeting by
hTrx1—To directly determine the roles of Cys residues in
fRMsr catalysis, we separatelymutated the three conserved Cys
in the yeast enzyme to Ser. Following affinity isolation, wild
type and mutant fRMsr proteins were pure as assessed by SDS-
PAGE. Mutation of each Cys dramatically affected enzyme
activity (the remaining activity was within background). Thus,
all three Cys were found to be critical for the catalytic activity of
fRMsr.
Wild type (WT) fRMsr and Cys mutants (C91S, C101S,
C125S, C101S/C125S) were further subjected to Cys targeting
by hTrx1 (C35S mutant)-immobilized resin (Fig. 9A). Since
hTrx1 is an efficient reductant of fRMsr in in vitro assays, we
hypothesized that mutation of its resolving Cys (i.e. C35S)
FIGURE 4. Sensitivity of wild type andmutant strains to oxidative stress. The indicated strains of S. cerevi-
siaewere grown in liquid medium containing 1 mM H2O2, and after the indicated periods of time, the viability
was assayed as described under “Experimental Procedures.” A, remaining viable fraction of WT and mutant
strains in YPD medium. B, remaining viable fraction of WT cells expressing fRMsr or a vector (control). C, plate
assay.Wild type andmutant yeast cells were incubated on YNB agarmedium, treated or notwith 1.2mMor 1.5
mM H2O2, and the pictures were taken after 3 days at 30 °C.
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would result in an intermediate that traps Cys32 (i.e. the cata-
lytic residue) in hTrx1 with the resolving Cys in fRMsr. Inter-
estingly, only WT and C101S mutant forms were trapped by
hTrx1 C35S, suggesting that the remaining Cys residues
(Cys125 and Cys91) are the resolving Cys that interact with
hTrx1. C101Smutant, but not other mutants, could still form a
disulfide between Cys91 and Cys125, reducible by hTrx1. Our
model of the fRMsr reaction mechanism is shown in Fig. 9B.
FIGURE 5. Life span analysis of yeast cells deficient in Msrs or overex-
pressing fRMsr. Replicative assays were used to determine life span of indi-
cated mutant and WT yeast cells by counting the number of daughter cells
produced by mother cells. Designation of yeast strains is as follows (A): A,
MsrA mutant: B, MsrB mutant: F, fRMsr mutant. Cells lacking fRMsr and
MsrA or MsrB, as well as cells with deletion of all three Msrs were analyzed in
YPD medium. B, life spans of cells overexpressing fRMsr and control cells
containing an empty vector were analyzed in minimal medium.
FIGURE 6. Substrate saturation curve of fRMsr. Vmax and Km values for free
Met-R-SO were determined by fitting experimental data, which were
obtained by a coupled assay, to the Michaelis-Menten equation.
FIGURE 7. Active site of yeast fRMsr. Met-R-SO was docked into the active
site as described under “Experimental Procedures.” This figure was created
with theUCSF Chimera package. Cys91 and Cys125 are shown in stick represen-
tation; Cys101 and Met-R-SO (also highlighted with green contour) are shown
in a ball and stick representation. The rest of the protein is shown in a ribbon
representation. Themodel shows that the substrate is oriented by both Cys101
and Cys125; at the same time, the reactive sulfoxide group points toward the
Cys101 sulfur atom (at a distance of 2.4 Å), which is a predicted catalytic Cys.
FIGURE 8.Mobility of Cys91, Cys125, and Cys101 residues following reduc-
tion of the disulfide between Cys125 and Cys91. The initial position (oxi-
dized fRMsr; Protein Data Bank code 1F5M) is shown in a gray stick represen-
tation, whereas green sticks show the residues after minimization. An early
intermediate structure (after the first 60 steps of minimization) during the
molecular dynamics minimization trajectory is also shown in a gray stick rep-
resentation. Cys125 moves much more extensively than the other two Cys
residues (moving away fromCys91 and closer to Cys101), supporting its role as
the resolving Cys. Cys101 is least mobile among the three Cys residues, sup-
porting its role as the catalytic residue. In our reduced andminimizedmodel,
the Cys125–Asp151 distance is 3.6 Å (6.6 Å in the oxidized form).
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DISCUSSION
MsrA and MsrB are the best known Msrs that catalyze the
reduction of Met-S-SO and Met-R-SO residues in proteins,
respectively. Although these enzymes are well characterized
structurally and functionally and their critical roles in the repair
of oxidizedMet residues in proteins have been established, how
free Met-SO is reduced by cells is not fully understood. MsrA
does show activity toward free Met-S-SO, but the activity of
MsrB toward free Met-R-SO is low. Previous studies suggested
the occurrence of an additional Msr that catalyzes the reduc-
tion of Met-R-SO (14, 22, 23). Recently, Lowther and co-work-
ers (24) purified and characterized a third Msr catalyzing
Met-SO reduction, designated fRMsr. This E. coli enzyme spe-
cifically reduced free Met-R-SO in in vitro assays, and its close
homologs occurred in other organisms, including S. cerevisiae,
suggesting that these homologs may function as fRMsr. The
mechanism used by the E. coli protein to catalyze the reduction
of freeMet-R-SO is not known. It is also unclear whether E. coli
fRMsr homologs indeed possess the same activity and whether
fRMsrs are responsible for the reduction of the bulk of free
Met-R-SO in cells. Our work has addressed these important
questions.
Comparative genomics analysis of fRMsr homologs in
sequenced genomes showed a mosaic distribution of this pro-
tein. It formed a clearly defined protein family whose members
occurred in single copies and were present in organisms in all
three domains of life. Approximately half of the sequenced bac-
terial genomes contained fRMsr (mostly various proteobacteria
and Firmicutes) (Fig. S1). The Firmicutes appear to comprise
the earliest branching phylum, which may be a Gram-positive
ancestor for all bacteria (27). Therefore, although many phyla
lacked this gene, it is possible that fRMsr could have been used
in the common ancestor of bacteria. In contrast, it was only
detected in three closely related archaeal organisms, sug-
gesting either a recent acquisition of fRMsr (e.g. by horizon-
tal gene transfer from bacteria) in Thermoplasmales or, less
likely, a complete loss of it in other archaeal phyla. In
eukaryotes, although about half of the sequenced organisms
possess fRMsr, it is absent from all multicellular organisms,
including higher plants and animals. It appears that either
fRMsr is not essential for these organisms or alternative
pathways evolved for Met-R-SO reduction. Besides, two
variants of fRMsr were identified on the basis of the pres-
ence/absence of a conserved Cys (Cys91 in yeast fRMsr). Both
subtypes had two additional conserved Cys residues that
were implicated in catalysis (24).
Using S. cerevisiae as a model organism, we characterized
fRMsr function in vivo and in vitro. The analysis of mutant cells
lacking fRMsr or combinations of fRMsr and MsrA and/or
MsrB deletions (i.e. double and triple Msr mutants) revealed
that fRMsr was responsible for the reduction of free Met-R-SO
in yeast cells, whereasMsrA was the main protein that reduced
free Met-S-SO in this organism.
Consistent with this function, the fRMsr deletion strain also
showed increased sensitivity to oxidative stress as well as a
reduced life span. In addition, although overexpression of
fRMsr had almost no effect on yeast life span, it protected cells
from oxidative stress caused by H2O2 treatment. Furthermore,
microarray analyses revealed elevated expression of fRMsr and
MsrA under the conditions of sulfur limitation in cells grown
aerobically, whereasMsrB expression did not change. We also
found that expression of yeast fRMsr in mammalian cells pro-
vided them with the ability to reduce free Met-R-SO, whereas
the initial cells were not able to consume this compound (8).
Altogether, these data established an important role of fRMsr in
the reduction of free Met-R-SO, which is a process by which
this protein provides Met for cellular metabolism. Taking into
account the finding that E. coli fRMsr specifically reduced free
Met-R-SO (24), we conclude that fRMsr is the main (and may
be the only) free Met-R-SO reductase and that it functions in
supplying cells withMet by salvaging oxidizedMet. Perhaps the
loss of fRMsr in plants and animals can be explained by lower
levels of free Met sulfoxides in these organisms that evolved
protective cover that controls their intraorganismal oxygen and
ROS levels.
It can be further inferred that fRMsr, as well as otherMsrs, is
needed primarily under stress conditions. Although the triple
fRMsr/MsrA/MsrB mutant cells showed a reduced life span
and increased sensitivity to H2O2 treatment, in the absence of
stress, this mutant was viable and grew on the Met-containing
medium similarly to wild type cells. These data are also consist-
ent with the previous proposal thatMsrs andMet contribute to
the cellular antioxidant system by scavenging ROS via reversi-
ble Met oxidation (9).
FIGURE 9. Cys targeting in fRMsr by mutant Trx and the proposed reac-
tion scheme of yeast fRMsr. A, wild type fRMsr and its four mutants (C91S,
C101S, C125S, C101S/C125S) were applied onto a resin immobilized with the
C35S form of hTrx1. Equal amounts (10 l) of initial (I), flow-through (F), and
DTT-eluted (E) fractions were analyzed byWestern blots (WB) with anti-yeast
fRMsr antibodies. B, proposed catalytic mechanism of yeast fRMsr (Type I).
Cys101 is proposed to be a catalytic Cys directly oxidized by Met-R-SO. Cys125
serves as the resolving Cys that initially forms a disulfidewith Cys101 and then
transfers this bond to Cys91 via thiol-disulfide exchange. The resulting Cys91–
Cys125 disulfide is then reduced by Trx or DTT.
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To further examine fRMsr, we characterized the recombi-
nant yeast enzyme. As expected, it showed specificity for the
reduction of free Met-R-SO but was not active with either free
Met-S-SO or dabsyl-Met-R-SO residues (the latter mimicking
Met-R-SO residues in proteins). No fRMsr mutant proteins
have previously been characterized, but a prediction for the
catalyticmechanismwasmade, based on the structural analysis
of the E. coli fRMsr, that the three Cys residues are involved in
catalysis (24). Indeed, the role of Cys residues in the catalysis by
fRMsr is consistent with the fact that both MsrA and MsrB
utilize Cys residues for Met-SO reduction. In some MsrA and
MsrB forms, these Cys are replaced with Sec.
Through molecular modeling and substrate docking, as well
as by employing methodologically diverse tools for active site
detection, we located the active site in the area of Cys101 and
Cys125, and both of these residues were implicated in catalysis
by multiple methods. The specific roles of these residues in
catalysis could not be resolved by site-directed mutagenesis,
since both residueswere essential for the catalytic activity of the
enzyme. However, we found that Cys101 is the best candidate
catalytic Cys through experimental analysis, computational
substrate-docking modeling, and Cys targeting search. We
tracked the best scoringmodels for the binding ofMet-R-SO in
the catalytic site of yeast fRMsr (Fig. S6 and Fig. 7). Interest-
ingly, the sulfoxide group ofMet-R-SO protrudes toward sulfur
of Cys101, probably leading to oxidation of this residue when it
attacks the sulfoxide. In contrast, Cys125 may play a supportive
role by arrangingMet-R-SO to interactwithCys101 in our dock-
ing model. Furthermore, protein dynamics suggested that
Cys125, in its stable conformation, comes close to Asp151, in
agreement with the previous observation on the crystal struc-
ture of the reduced active site of yeast fRMsr (45).
Our computational analysis suggested that Cys125 is flexible
andmoves between two different conformers (Fig. 8), one close
to Cys91 (in the oxidized protein) and the other near Asp151 (in
the reduced enzyme). These observations clearly support the
model (Fig. 9)wherein the flexibleCys125 is the principal resolv-
ing Cys. Its two conformations suggest a role in transferring
oxidizing equivalents resulting in the Cys91–Cys125 disulfide.
Consistent with this model, Cys targeting in fRMsr by mutant
Trx demonstrated that Cys125 and Cys91 could interact with
this reductant, whereas Cys101 could not. Surprisingly, muta-
tion of either of these residues inactivated the enzyme even in a
DTT-dependent reaction, suggesting that the catalytic residue
is not accessible forDTT.Wepropose that the threeCys (Cys91,
Cys101, and Cys125) follow classical disulfide exchange reac-
tions, initiated by oxidation of Cys101 (46).
Cys91 is present only in one of two fRMsr forms (Type I),
suggesting that it cannot be universally essential for catalysis.
However, this residue is essential for the catalysis by yeast
fRMsr. Additional fRMsr forms (Type II) will need to be inves-
tigated and compared with Type I enzymes to confirm differ-
ences in resolving residues.
Finally, it is clear that fRMsr is the main enzyme responsible
for the reduction of free Met-R-SO in S. cereivisiae and poten-
tially in other organisms from the three domains of life. It is a
third member of the group of enzymes that reduce Met sulfox-
ides. Whereas MsrA is responsible for the reduction of both
free and protein-based Met-S-SO, the reduction of Met-R-SO
is carried out by two proteins: MsrB, which reduces Met-R-SO
residues in proteins, and fRMsr, which accounts for the reduc-
tion of free Met-R-SO. All three enzymes are widespread, indi-
cating the importance of catalytic Met sulfoxide reduction in
biology.
REFERENCES
1. Weissbach, H., Resnick, L., and Brot, N. (2005) Biochim. Biophys. Acta
1703, 203–212
2. Weissbach, H., Etienne, F., Hoshi, T., Heinemann, S. H., Lowther, W. T.,
Matthews, B., St. John. G., Nathan, C., and Brot, N. (2002) Arch. Biochem.
Biophys. 397, 172–178
3. Slyshenkov, V. S., Shevalye, A. A., Liopo, A. V., and Wojtczak, L. (2002)
Acta Biochim. Pol. 49, 907–916
4. Kantorow, M., Hawse, J. R., Cowell, T. L., Benhamed, S., Pizarro, G. O.,
Reddy, V. N., and Hejtmancik, J. F. (2004) Proc. Natl. Acad. Sci. U. S. A.
101, 9654–9659
5. Picot, C. R., Petropoulos, I., Perichon, M., Moreau, M., Nizard, C., and
Figuet, B. (2005) Free Radic. Biol. Med. 39, 1332–1341
6. Boschi-Muller, S., Olry, A., Antoine, M., and Branlant, G. (2005) Biochim.
Biophys. Acta 1703, 231–238
7. Cabreiro, F., Picot, C. R., Perichon,M., Mary, J., Friguet, B., and Petropou-
los, I. (2007) Biochimie (Paris) 89, 1388–1395
8. Lee, B. C., Le, D. T., and Gladyshev, V. N. (2008) J. Biol. Chem. 283,
28361–28369
9. Levine, R. L., Berlett, B. S., Moskovitz, J., Mosoni, L., and Stadtman, E. R.
(1999)Mech. Ageing Dev. 107, 323–332
10. Stadtman, E. R., Moskovitz, J., Berlett, B. S., and Levine, R. L. (2002)Mol.
Cell. Biochem. 234/235, 3–9
11. Ezraty, B., Grimaud, R., Hassouni, M. E., Moinier, D., and Barras, F. (2004)
EMBO J. 23, 1868–1877
12. Moskovitz, J., Bar-Noy, S., Williams,W.M., Requena, J., Berlett, B. S., and
Stadtman, E. R. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 12920–12925
13. Ruan, H., Tang, X. D., Chen, M.-L., Joiner, M.-L. A., Sun, G., Brot, N.,
Weissbach, H., Heinemann S. H., Iverson, L., Wu, C.-F., and Hoshi, T.
(2002) Proc. Natl. Acad. Sci. U. S. A. 99, 2748–2753
14. Koc, A., Gasch, A. P., Rutherford, J. C., Kim, H.-Y., and Gladyshev, V. N.
(2004) Proc. Natl. Acad. Sci. U. S. A. 101, 7999–8004
15. Kim, H.-Y., and Gladyshev, V. N. (2004)Mol. Biol. Cell 15, 1055–1064
16. Boschi-Muller, S., Azza, S., Sanglier-Cianferani, S., Talfournier, F., Dors-
selear, A. V., and Branlant, G. (2000) J. Biol. Chem. 275, 35908–35913
17. Lowther,W. T., Brot, N.,Weissbach, H., Honek, J. F., andMatthews, B.W.
(2000) Proc. Natl. Acad. Sci. U. S. A. 97, 6463–6468
18. Taylor, A. B., Benglis, D.M. Jr., Dhandayuthapani, S., andHart, P. J. (2003)
J. Bacteriol. 185, 4119–4126
19. Lowther,W. T., Weissbach, H., Etienne, F., Brot, N., andMatthews, B.W.
(2002) Nat. Struct. Biol. 9, 348–352
20. Kim, H.-Y., and Gladyshev, V. N. (2005) PLoS Biol. 3, e375
21. Boschi-Muller, S., Gand, A., and Branlant, G. (2008) Arch. Biochem. Bio-
phys. 474, 266–273
22. Etienne, F., Spector, D., Brot, N., andWeissbach, H. (2003) Biochem. Bio-
phys. Res. Commun. 300, 378–382
23. Spector, D., Etienne, F., Brot, N., andWeissbach, H. (2003) Biochem. Bio-
phys. Res. Commun. 302, 284–289
24. Lin, Z., Johnson, L. C.,Weissbach, H., Brot, N., Lively,M.O., and Lowther,
W. T. (2007) Proc. Natl. Acad. Sci. U. S. A. 104, 9597–9602
25. Altschul, S. F., Gish,W.,Miller,W.,Myers, E.W., and Lipman, D. J. (1990)
J. Mol. Biol. 215, 403–410
26. Tatusov, R. L., Galperin, M. Y., Natale, D. A., and Koonin, E. V. (2000)
Nucleic Acids Res. 28, 33–36
27. Ciccarelli, F. D., Doerks, T., von Mering, C., Creevey, C. J., Snel, B., and
Bork, P. (2006) Science 311, 1283–1287
28. Higgins,D., Thompson. J., Gibson, T., Thompson, J. D.,Higgins,D.G., and
Gibson, T. J. (1994) Nucleic Acids Res. 22, 4673–4680
29. Felsenstein, J. (1989) Cladistics 5, 164–166
30. Guindon, S., and Gascuel, O. (2003) Syst. Biol. 52, 696–704
Functional Analysis of FreeMet-R-SO from S. cerevisiae
FEBRUARY 13, 2009•VOLUME 284•NUMBER 7 JOURNAL OF BIOLOGICAL CHEMISTRY 4363
31. Ronquist, F., and Huelsenbeck, J. P. (2003) Bioinformatics 19,
1572–1574
32. Laurie, A. T., and Jackson, R. M. (2005) Bioinformatics 21, 1908–1916
33. Ondrechen,M. J., Clifton, J. G., and Ringe, D. (2001). Proc. Natl. Acad. Sci.
U. S. A. 98, 12473–12478 (33)
34. Wei, Y., Ko, J., Murga, L. F., and Ondrechen, M. J. (2007) BMC Bioinfor-
matics 8, 119
35. Gordon, J. C.,Myers, J. B., Folta, T., Shoja, V., Heath, L. S., andOnufriev, A.
(2005) Nucleic Acids Res. 33,W368–W371
36. Ko, J., Murga, L. F., Andre, P., Yang, H., Ondrechen, M. J., Williams, R. J.,
Agunwamba, A., and Budil, D. E. (2005) Proteins Struct. Funct. Bioinfor-
mat. 59, 183–195
37. Deleted in proof
38. Deleted in proof
39. Deleted in proof
40. Goldstein, A. L., and McCusker, J. H. (1999) Yeast 15, 1541–1553
41. Le, D. T., Liang, X., Fomenko, D. E., Raza, A. S., Chong, C.-K., Carlson,
B. A., Hatfield, D. L., and Gladyshev, V. N. (2008) Biochemistry 47,
6685–6694
42. Tai, S. L., Boer, V. M., Daran-Lapujade, P., Walsh, M. C., de Winde, J. H.,
Daran, J. M., and Pronk, J. T. (2005) J. Biol. Chem. 280, 437–447
43. Smetana, J. H., and Zanchin, N. I. (2007) FEBS J. 274, 5891–5904
44. Kryukov, G. V., Kumar, R. A., Koc, A., Sun, Z., andGladyshev, V. N. (2002)
Proc. Natl. Acad. Sci. U. S. A. 99, 4245–4250
45. Ho, Y. S., Burden, L. M., and Hurley, J. H. (2000) EMBO J., 19,
5288–5299
46. Boschi-Muller, S., Azza, S., Sanglier-Cianferani, S., Talfournier, F., Van
Dorsselear, A., and Branlant, G. (2002) J. Biol. Chem., 17, 35908–35913
Functional Analysis of FreeMet-R-SO from S. cerevisiae
4364 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 284•NUMBER 7•FEBRUARY 13, 2009
